CompuGroup Medical SE & Co. KGaA announced that effective as of March 2024, the Board of Directors appoints Daniela Hommel as Chief Financial Officer. Daniela Hommel has held various finance and controlling positions in the Fresenius Group since 2012.

Since 2018 she was responsible for the performance of the Fresenius Helios segment as Chief Financial Officer. In 2022, she assumed the role of Chief Financial and Innovation Officer of Helios Global Health GmbH with the aim of improving access to healthcare worldwide with new forms of care. In addition, she has assumed business responsibility for Fresenius?

digital daughter Curalie as CEO since 2022. Prior to that, she spent 14 years at KPMG, most recently as the responsible audit partner in the healthcare sector. Until she joins CompuGroup Medical, CEO Michael Rauch will continue to be responsible for the CFO role on an interim basis.